U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Substance Use Tools & Resources   

Read the Guide

This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 [PDF 0.69 MB] and Volume 2 [PDF 1.28 MB] of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.

Displaying 151 - 160 of 978

The Drug Abuse Warning Network (DAWN) National Estimates from Drug-Related Emergency Department Visits, 2023

The Drug Abuse Warning Network (DAWN) National Estimates from Drug-Related Emergency Department Visits, 2023 report provides weighted national estimates of substance-related emergency department visits.
Format
Report/Paper/Issue Brief
Audience
First Responders
Behavioral Health Providers
Medical Providers
Source
Substance Abuse and Mental Health Services Administration (SAMSHA)
Year
Resource Type
PDF
File Size
647 KB

The Intersection of Substance Misuse and Suicide Prevention

During this webinar, prevention experts explore the data and research on the intersection of substance use and suicide and cover identified evidence-based substance use prevention programs that address risk of suicide, and potential opportunities for collaborations that exist.
Format
Webinar/Video
Audience
Behavioral Health Providers
Other Team Members
Graduate Education
States
Policymakers and Payers
Source
Prevention Technology Transfer Center Network (PTTC)
Year
Resource Type
Video

The Legal Landscape for Opioid Treatment Agreements

This article surveyed laws and regulations in all 50 states and the District of Columbia, as well as criminal and civil judicial decisions in which opioid treatment agreements were discussed as evidence, finding minimal evidence that they effectively reduce opioid misuse or improve patient outcomes.
Format
Report/Paper/Issue Brief
Audience
Policymakers and Payers
States
Source
The Milbank Quarterly
Year
Resource Type
Article

The Pharmacy Access to Resources and Medication for Opioid Use Disorder (PhARM-OUD) Guideline

This document seeks to help pharmacists balance the risks and benefits to themselves, their employer, and, most importantly, their patients that accompany each buprenorphine dispensing decision. The overarching recommendation of this document is that pharmacists should make a good faith effort to provide high quality care to persons with OUD by always maintaining an adequate supply of buprenorphine and filling legitimate prescriptions in a timely manner.
Format
Report/Paper/Issue Brief
Audience
Other Team Members
Source
National Association of Boards of Pharmacy and National Community Pharmacists Association
Year
Resource Type
PDF
File Size
606 KB

Treating Tranq: Practical Lessons from the Epicenter of the Xylazine Crisis

This 75-minute on-demand session from the ASAM 55th Annual Conference addresses how to identify and treat xylazine-associated wounds with patient-centered strategies.This didactic case-based session addresses national xylazine trends, drug properties, overdose and withdrawal management, wound care, pain management, and harm reduction with a focus on patient-centered care.
Format
Web-Based Course
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
American Society of Addiction Medicine (ASAM)
Year
Resource Type
Video

Treatment Episode Data Set (TEDS) 2022: Admissions to and Discharges from Substance Use Treatment Services Reported by Single State Agencies

The Treatment Episode Data Set (TEDS) collects episode-level data on clients aged 12 and older receiving substance use treatment services from facilities that are licensed or certified by their respective single state agencies (SSAs). The national outcome measures presented in this report include stability in housing, employment status, criminal justice involvement, social support, retention in treatment, and abstinence.
Format
Report/Paper/Issue Brief
Audience
States
Behavioral Health Providers
Source
Substance Abuse and Mental Health Services Administration (SAMSHA)
Year
Resource Type
PDF
File Size
8.8 MB

Treatment for Opioid Use Disorder: Population Estimates — United States, 2022

This article reviews medication for opioid use disorder (MOUD) treatments in the United States from data pulled from the 2022 National Survey on Drug Use and Health.
Format
Report/Paper/Issue Brief
Audience
Policymakers and Payers
States
Behavioral Health Providers
Communities
Source
Centers for Disease Control and Prevention (CDC)
Year
Resource Type
PDF
File Size
435 KB

Treatment for Suicidal Ideation, Self-harm, and Suicide Attempts Among Youth

The goal of this guide is to provide interventions to treat for suicidal ideation, self-harm, and suicide attempts among youth. It provides research on implementation and examples of the ways that these recommendations can be implemented.

Format
Guide
Audience
Behavioral Health Providers
Medical Providers
Other Team Members
Schools
Source
Substance Abuse and Mental Health Services Administration
Year
Resource Type
PDF